Bridging the Shocking Knowledge Gap in Women’s Health: Key Insights and Solutions

As a former pediatrician in Karachi, Pakistan, I cared for countless premature infants born due to pre-eclampsia. These tiny lives often rested in the palm of my hand, struggling for breath. Unfortunately, not all of them survived.

The complexities of pregnancy complications like pre-eclampsia remain poorly understood. We lack clarity on the root causes and preventive measures for premature births, contributing to the global maternal and infant mortality crisis. Every day, over 700 women and 6,500 newborns lose their lives due to pregnancy or childbirth complications. The highest rates are in sub-Saharan Africa and South Asia, exacerbated by weak healthcare systems, inequitable access to care, extreme poverty, and inadequate infrastructure.

Astonishing knowledge gaps exist across women’s health issues, including menopause. The norm of women suffering for a decade seems acceptable, yet is scarcely recognized as a significant issue. This oversight stems not from scientific challenges but from a pervasive apathy. Women’s experiences have been largely overlooked, impacting what is researched and what remains unaddressed.

Currently, less than 1 percent of healthcare research focuses on women’s health outcomes outside of cancer. This underinvestment and the lack of female participation in clinical trials leave fundamental questions in women’s health unanswered. For instance, while we know the symptoms of heart disease—the leading cause of death for women globally—differ by individual, the reasons remain a mystery. Moreover, the pathways for drugs into the brain are known, yet how they affect the female reproductive system is largely unexplored, unlike the extensive knowledge we possess about men’s health, such as the effects of Viagra.

A Ray of Hope

Progress is being made, and I’ve observed a shift towards serious discussions on investing in women’s health at global health and medical innovation conferences. Decision-makers and investors are beginning to acknowledge the severity of the issue and the potential benefits of addressing it following decades of neglect.

Recognizing the challenges is only the first step; we must actively allocate resources and focus on the multifaceted issues surrounding women’s health.

I am particularly excited about the transformative potential of innovative research and tools. For example, the vaginal microbiome—a balance of beneficial and harmful bacteria—has only recently gained attention. Understanding its role in pregnancy outcomes, like preterm birth, and women’s vulnerability to infections like HIV is crucial.

My team at the Gates Foundation is funding research to uncover how the vaginal microbiome affects pregnancy outcomes and women’s susceptibility to STIs. Although we’re in early stages, promising innovations are emerging that could benefit millions of women.

For instance, interventions promoting healthy bacteria dominance in the vagina might help prevent STIs. Conditions like bacterial vaginosis, while mild, can lead to severe pregnancy complications, including premature birth and an increased risk of postnatal issues such as chronic pain and infertility.

Last year, the Gates Foundation committed to $2.5 billion for women’s health innovation. However, this amount is insufficient. We need to bolster collaboration with public and private sector entities globally. The UK has a unique opportunity to build on its health innovation reputation, enhancing lives both domestically and internationally while advancing its vital economic sectors.

Investing in women’s health equates to investing in their lives and well-being. A healthy woman fosters creativity, is more engaged with her family, and is an active participant in her community. This is a fundamental truth. On this International Women’s Day, let’s turn this truth into action by urging leaders to prioritize and resource women’s health initiatives now.

Anita Zaidi is Chair of Gender Equality at the Gates Foundation